Keyword: Harvard University
A team led by the Wyss Institute has created reversible platelets that they say may not only reduce blood clots but might also prevent cancer from spreading.
A connection between TDP-43, which has been implicated in ALS, and another gene could yield new approaches to treating the disease.
The series B round will support the startup’s efforts to build a portfolio of subsidiaries with assets targeting eight aging pathways.
The Harvard researcher who first discovered the "exercise hormone" irisin reports it may be useful in bone formation.
RootPath raised $7 million to develop a T-cell therapy platform for cancer treatment that addresses the shortcomings of current technology.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
One of the founding scientists of Illumina has come out with a new gene-sequencing software startup that aims to tackle antimicrobial resistance.
New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.
Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $87 million in series A funding.
